Predicta Biosciences Secures $5.2M to Transform the Diagnosis, Treatment and Monitoring of Blood Cancers
Founded by leading cancer genomics researchers and clinicians, Predicta is developing a novel, non-invasive diagnostic for Multiple Myeloma Predicta Biosciences team (Photo: Business Wire) July 16, 2024 05:00 AM Pacific Daylight Time BOSTON–(BUSINESS WIRE)–Predicta Biosciences,…